Download PDF
Dialyse aktuell 2022; 26(01): 18-19
DOI: 10.1055/a-1521-4309
Journal-Club

Internationale Studien im Jahre 2021

COVID-19 und Peritonealdialyse
Ferruh Artunc
› Further Information
Also available at
    Permissions and Reprints

In diesem „Journal-Club“ soll eine Übersicht wichtiger Studien zum Thema „COVID-19 und Peritonealdialyse (PD)“ aus dem Jahr 2021 gegeben werden.



Publication History

Article published online:
08 February 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Perl J, Thomas D, Tang Y. et al COVID-19 among Adults Receiving Home versus In-Center Dialysis. Clin J Am Soc Nephrol 2021; 16: 1410-1412
    CrossrefPubMedSearch in Google Scholar
  • 2 Candellier A, Goffin E. Can SARS-CoV-2 be found in the effluent from peritoneal dialysis patients?. Clin Kidney J 2021; 14: 2124-2126
    CrossrefPubMedSearch in Google Scholar
  • 3 Vischini G, D’Alonzo S, Grandaliano G, D’Ascenzo FM. SARS-CoV-2 in the peritoneal waste in a patient treated with peritoneal dialysis. Kidney Int 2020; 98: 237-238
    CrossrefPubMedSearch in Google Scholar
  • 4 Chen W, Caplin N, El Shamy O. et al Use of peritoneal dialysis for acute kidney injury during the COVID-19 pandemic in New York City: a multicenter observational study. Kidney Int 2021; 100: 2-5
    CrossrefPubMedSearch in Google Scholar
  • 5 Rodríguez-Espinosa D, Broseta JJ, Maduell F. et al Humoral response of the mRNA-1273 SARS-CoV-2 vaccine in peritoneal dialysis patients. Kidney Int 2021; 100: 476-477
    CrossrefPubMedSearch in Google Scholar
  • 6 Yanay NB, Freiman S, Shapira Ma. et al Experience with SARS-CoV-2 BNT162b2 mRNA vaccine in dialysis patients. Kidney Int 2021; 99: 1496-1498
    CrossrefPubMedSearch in Google Scholar
  • 7 Patecki M, Merscher S, Dumann H. et al Similar humoral immune responses in peritoneal dialysis and haemodialysis patients after two doses of the SARS-CoV-2 vaccine BNT162b2. Perit Dial Int 2022; 42: 100-101
    CrossrefPubMedSearch in Google Scholar
  • 8 Wei J, Stoesser N, Matthews PC. et al Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom. Nat Microbiol 2021; 06: 1140-1149
    CrossrefPubMedSearch in Google Scholar
  • 9 Ben-Dov IZ, Oster Y, Tzukert K. et al Impact of tozinameran (BNT162b2) mRNA vaccine on kidney transplant and chronic dialysis patients: 3–5 months followup. J Nephrol 2022 Jan 6 1-12
    Crossref
  • 10 Speer C, Schaier M, Nusshag C. et al Longitudinal Humoral Responses after COVID-19 Vaccination in Peritoneal and Hemodialysis Patients over Twelve Weeks. Vaccines (Basel) 2021; 09: 1130
    CrossrefPubMedSearch in Google Scholar
  • 11 Ben-Dov IZ, Tzukert K, Aharon M. et al Response to Tozinameran (BNT162b2) booster in twice-vaccinated kidney transplant and maintenance dialysis patients. medRxiv. 2021 October 20
    CrossrefSearch in Google Scholar